You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in China

Feb 2011

Price: $2,400

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in China with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in China, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in China for free:

The Consumer Health in China market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in China?
  • What are the major brands in China?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Recovering economy contributed to consumer health market growth

China’s macro economy enjoyed a strong recovery in 2010, with GDP growth expected to exceed 10% in current value terms. The consumer health market also received a boost from returning confidence among both consumers and manufacturers. The market for vitamins and dietary supplements, in particular, whose performance is more closely correlated with the economic situation, showed a significant increase in its growth rate in 2010, compared with its poor performance in 2009.

National health care reform brought uncertainty to the industry

2010 was the second year of China’s national health care reform, started in early 2009. One of the major aims of the reform is to reduce the overall cost of medicine for Chinese consumers in both the short term and long term. Hence, controlling the retail selling prices of OTC products and reducing the mark-up between different distributors and retailers are the major methods to realise this goal in the short term. However, due to the lack of detailed regulations as well as different policies in different regions of the country, it is still not clear what the policy’s long-term impact will be for the industry.

Direct selling companies consolidate their leading position

Direct selling companies achieved relatively robust growth during 2010, with the rapid growth of vitamins and dietary supplements. Leading companies such as Amway (China) Co Ltd, Infinitus (China) Co Ltd and Perfect (China) Co Ltd, all gained higher market share in 2010. In contrast to the OTC market which is dominated more by the government’s policies, the performance of vitamins and dietary supplements is more closely determined by economic factors such as consumer confidence, personal disposable income and standard of living. Hence, direct selling companies which are specialised in vitamins and dietary supplements benefited from the increased demand from the local market during 2010.

Non-store retailing indicated faster growth

Compared with traditional retail channels such as supermarkets and hypermarkets which faced pressures from the rising costs of labour, logistics and rent, non-store-based retailing channels such as direct selling and internet retailing indicated a more dynamic increase in 2010. The outstanding performance of direct selling companies contributed to the sustained growth of direct selling, while the explosive growth in internet retailing in 2010 also prompted more companies to enter this market. With the increased number of young consumers willing to accept new concepts in this market, the development of non-store-based retailing is expected to grow continuously over the forecast period.

Healthy growth is expected to continue during the forecast period

China’s consumer health market is predicted to experience relatively healthy growth during the forecast period, not only because of the improved economic situation in the country, but also due to better health-consciousness among local consumers. Many new concepts of health and wellness such as herbal/traditional products, organic products as well as natural green products are already quite familiar to local consumers, after many years of consumer education by leading companies. New product development and innovation are still regarded as the major driving factors for the industry’s long-term development.

Table of Contents

Table of Contents

Consumer Health in China - Industry Overview

EXECUTIVE SUMMARY

Recovering economy contributed to consumer health market growth

National health care reform brought uncertainty to the industry

Direct selling companies consolidate their leading position

Non-store retailing indicated faster growth

Healthy growth is expected to continue during the forecast period

KEY TRENDS AND DEVELOPMENTS

Economic development contributed to the market recovery

Concentration and centralisation continued to be the industry’s main focus

Ageing population stimulates growth in related categories

Improving awareness of natural and herbal concepts in the market

National health care reform expected to have long-term impact on the industry

TERRITORY KEY TRENDS AND DEVELOPMENTS

East China

Mid China

North and Northeast China

Northwest China

South China

Southwest China

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Sales of Consumer Health by Region: Value 2005-2010
  • Table 6 Sales of Consumer Health by Region: % Value Growth 2005-2010
  • Table 7 Consumer Health Company Shares by Value 2006-2010
  • Table 8 Consumer Health Brand Shares by Value 2007-2010
  • Table 9 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 10 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 11 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 12 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015
  • Table 13 Forecast Sales of Consumer Health by Region: Value 2010-2015
  • Table 14 Forecast Sales of Consumer Health by Region: % Value Growth 2010-2015

APPENDIX

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/Self-care and Preventative Medicine

Generics

Switches

DEFINITIONS

  • Summary 1 Research Sources

Consumer Health in China - Company Profiles

Amway (China) Co Ltd - Consumer Health - China

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 3 Amway (China) Co Ltd: Competitive Position 2010

CR Sanjiu Medical & Pharmaceutical Co Ltd - Consumer Health - China

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 6 CR Sanjiu Medical & Pharmaceutical Co Ltd: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 7 CR Sanjiu Medical & Pharmaceutical Co Ltd: Competitive Position 2010

Infinitus (China) Co Ltd - Consumer Health - China

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 9 Infinitus (China) Co Ltd: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 10 Infinitus (China) Co Ltd: Competitive Position 2010

Jiangzhong Pharmaceutical Co Ltd - Consumer Health - China

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 13 Jiangzhong Pharmaceutical Co Ltd: Competitive Position 2010

Perfect (China) Co Ltd - Consumer Health - China

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 15 Perfect (China) Co Ltd: Competitive Position 2010

Shandong Dong-E E-Jiao Co Ltd - Consumer Health - China

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 18 Shandong Dong-E E-Jiao Co Ltd: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 19 Shandong Dong-E E-Jiao Co Ltd: Competitive Position 2010

Stone Group Holdings Ltd - Consumer Health - China

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 22 Stone Group Holdings Ltd: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 23 Stone Group Holdings Ltd: Competitive Position 2010

Tibet Cheezheng Tibetan Medicine Co Ltd - Consumer Health - China

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 26 Tibet Cheezheng Tibetan Medicine Co Ltd: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 27 Tibet Cheezheng Tibetan Medicine Co Ltd: Competitive Position 2010

Xian Janssen Pharmaceutical Ltd - Consumer Health - China

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 29 Xian Janssen Pharmaceutical Ltd: Competitive Position 2010

Yunnan Baiyao Group Co Ltd - Consumer Health - China

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 32 Yunnan Baiyao Group Co Ltd: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 33 Yunnan Baiyao Group Co Ltd: Competitive Position 2010

Adult Mouth Care in China - Category Analysis

HEADLINES

TRENDS

  • There are potential threats from other markets, such as oral care in the beauty and personal care market. For example, Chinese consumers are more likely to choose oral care products, such as mouthwashes/dental rinses, to prevent oral ailments, instead of dealing with oral problems when they occur. Oral care products are easier to purchase and to use, thus are highly welcomed by Chinese consumers.

CATEGORY DATA

  • Table 15 Sales of Adult Mouth Care: Value 2005-2010
  • Table 16 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 17 Adult Mouth Care Company Shares by Value 2006-2010
  • Table 18 Adult Mouth Care Brand Shares by Value 2007-2010
  • Table 19 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 20 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in China - Category Analysis

HEADLINES

TRENDS

  • In line with the stable performance of China’s OTC market, analgesics also demonstrated stable growth during 2010, with current value growth of just over 9% and total sales of RMB5.1 billion by the end of the year. Improved awareness of self-medication and rapid expansion of retail channels such as chained chemists/pharmacies were the major reasons for the sustained growth of the market during the review period. In contrast to more severe ailments, people in China are quite accustomed to purchasing standard systemic analgesics or topical analgesics/anaesthetic directly from chemists/pharmacies, largely due to convenience and accessibility.

SWITCHES

COMPETITIVE LANDSCAPE

  • GlaxoSmithKline (Tianjin) Pharm Co Ltd continued to consolidate its leading position in analgesics in 2010. The company’s top-selling product, Fenbid, maintained its steady increase during the review period, due to its successful marketing activities which helped to build Fenbid into one of the most famous analgesic products in China. Similarly, the company has been very active establishing its distribution network across the country, which is regarded as another reason for its outstanding performance in China.

PROSPECTS

  • With the steady increase in the population of older Chinese people as well as the improvement in awareness of self-medication over the forecast period, the market for analgesics is expected to post a CAGR of almost 8% in constant value terms over 2010-2015. Sales are expected to reach RMB7.4 billion by the end of 2015 and per capita expenditure on analgesic products is expected to increase from RMB3.8 in 2010 to RMB5.4 in 2015.

CATEGORY DATA

  • Table 21 Sales of Analgesics by Category: Value 2005-2010
  • Table 22 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 23 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
  • Table 24 Analgesics Company Shares by Value 2006-2010
  • Table 25 Analgesics Brand Shares by Value 2007-2010
  • Table 26 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 27 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in China - Category Analysis

HEADLINES

TRENDS

  • The market for calming and sleeping products experienced moderate growth during 2010, with year-on-year growth of just over 7%. The rising number of elderly people in China has driven demand for these kinds of products. However, since many health food products also claim to provide similar functions to calming and sleeping products in China, the OTC market for such products has come under considerable pressure and therefore registered only moderate growth during the review period.

SWITCHES

COMPETITIVE LANDSCAPE

  • Jilin Aodong Pharm Group Co Ltd continued to be the number one player in calming and sleeping, with a market share of over 50% in 2010. The company’s core brand, An Shen Bu Nao Ye, continued its stable growth in 2010 and realised total sales of RMB193 million. As a brand with more than 20 years’ history, An Shen Bu Nao Ye is well known among Chinese consumers, after many years’ continuous efforts by the company in terms of TV advertising.

PROSPECTS

  • The market for calming and sleeping is expected to experience moderate growth during the forecast period, with a CAGR of 6% in constant value terms over 2010-2015. Herbal/traditional products will continue to account for the bulk of the market, due to local consumer preferences. The ageing population of China is regarded to be the most important driving force of the market in the following years.

CATEGORY DATA

  • Table 28 Sales of Calming and Sleeping: Value 2005-2010
  • Table 29 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 30 Calming and Sleeping Company Shares by Value 2006-2010
  • Table 31 Calming and Sleeping Brand Shares by Value 2007-2010
  • Table 32 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 33 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in China - Category Analysis

HEADLINES

TRENDS

  • Sales of cough, cold and allergy remedies (CCA) increased by 10% in current value terms in 2010 in China. As one of the largest categories in the OTC market, Cough, cold and allergy remedies products are regarded as one of the most familiar and popular remedies for Chinese consumers, after many years’ successful consumer education. Compared with the quicker growth of sales in 2009, performance in 2010 was a return to more normal levels.

SWITCHES

COMPETITIVE LANDSCAPE

  • CR Sanjiu Medical & Pharmaceutical Co Ltd led cough, cold and allergy remedies in 2010, due to the strong performance of its core product, 999 Gan Mao Ling. Benefiting from the boom in traditional/herbal CCA products during the review period, the company’s top-selling brand, 999 Gan Mao Ling, experienced robust growth. Successful TV advertising described the product as offering a combined effect of herbal/traditional products and standard products. By the end of 2010, the brand’s overall retail sales value had almost reached RMB1 billion, reflecting a market share of almost 8%.

PROSPECTS

  • The market for cough, cold and allergy remedies is expected to maintain stable growth over the forecast period. Sales are expected to post a CAGR of over 7% in constant value terms over 2010-2015. As with several other categories in the OTC market, demand for CCA products is quite stable, and tends to rise in line with population growth.The average growth of the market will continued to be stable, mainly due to the sustainable increased demand in the following years.

CATEGORY DATA

  • Table 34 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 35 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 36 Sales of Decongestants by Category: Value 2005-2010
  • Table 37 Sales of Decongestants by Category: % Value Growth 2005-2010
  • Table 38 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 39 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 40 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2006-2010
  • Table 41 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2007-2010
  • Table 42 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 43 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in China - Category Analysis

HEADLINES

TRENDS

  • The market for digestive remedies continued to enjoy stable growth in 2010, in line with the gradual increase in demand for these kinds of remedies in China. Sales reached RMB4.8 billion by the end of 2010, and accounted for some 14% of the total OTC market. As one of the key categories in the OTC market in China, digestive remedies are regarded as some of the most familiar OTC products among local consumers.

SWITCHES

COMPETITIVE LANDSCAPE

  • Jilin Xiuzheng Pharmaceutical Co Ltd continued to be the leading company in digestive remedies, accounting for over 16% of value sales in 2010. As a leading domestic OTC company, it has several well-known brands such as Si Da Shu, Wei Da Ning and Xiao Mi Shuan across many categories of the OTC market. Among these brands, its flagship brand, Si Da Shu, was the number one brand in digestive remedies in China, after several years’ efforts by the company through marketing activities.

PROSPECTS

  • The market for digestive remedies in China is expected to continue its stable growth over the forecast period. Sales are expected to post a CAGR of over 7% in constant value terms over 2010-2015, to reach over RMB6.8 billion by 2015. As a relatively mature category in the OTC market, prospects for digestive remedies are fairly moderate over the forecast period.

CATEGORY DATA

  • Table 44 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 45 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 46 Digestive Remedies Company Shares by Value 2006-2010
  • Table 47 Digestive Remedies Brand Shares by Value 2007-2010
  • Table 48 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 49 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Emergency Contraception in China - Category Analysis

HEADLINES

TRENDS

  • The emergency contraception market in 2010 enjoyed 9% current value growth, higher than the 7% growth in 2009. Although a scandal concerning the side effects of levonorgestrel including extrauterine pregnancy, which involved Yuting, created some panic at the beginning of 2010, it did not affect the growth trend due to the growing demand for emergency contraception.

COMPETITIVE LANDSCAPE

  • In emergency contraception, the competitive landscape remains largely unchanged in terms of the leading companies. Domestic brands continued to dominate the market over the review period, with the top three brands all domestic ones.

PROSPECTS

  • Emergency contraception is expected to continue its healthy growth, with a CAGR of 6% in constant value terms over the forecast period, to reach sales of almost RMB1.6 billion in 2015. The upward growth trend is supported by fast-growing demand, with the main stimulus being the increasing rate of pre-marital sex in China.

CATEGORY DATA

  • Table 50 Sales of Emergency Contraception: Value 2005-2010
  • Table 51 Sales of Emergency Contraception: % Value Growth 2005-2010
  • Table 52 Emergency Contraception Company Shares by Value 2006-2010
  • Table 53 Emergency Contraception Brand Shares by Value 2007-2010
  • Table 54 Forecast Sales of Emergency Contraception: Value 2010-2015
  • Table 55 Forecast Sales of Emergency Contraception: % Value Growth 2010-2015

Eye Care in China - Category Analysis

HEADLINES

TRENDS

  • Dry eye drops continued to dominate standard eye care, with over 55% of value sales in 2010. Red eye drops continued to rank second, with just over 25% of value sales in 2010.

CATEGORY DATA

  • Table 56 Sales of Eye Care by Category: Value 2005-2010
  • Table 57 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 58 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 59 Eye Care Company Shares by Value 2006-2010
  • Table 60 Eye Care Brand Shares by Value 2007-2010
  • Table 61 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 62 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in China - Category Analysis

HEADLINES

TRENDS

  • Herbal/traditional products posted robust growth during the review period. On the one hand, the sustained growth of the overall consumer health market in the past few years underpinned demand for herbal/traditional products. On the other hand, there were a number of issues regarding side effects associated with certain chemical products such as Johnson & Johnson’s recall issue with Tylenol in 2010, which, to some extent contributed to the demand for herbal/traditional products, since most Chinese consumers believe that herbal/traditional products cause less harm to the body in the short and long term. As a result, growth of herbal/traditional products in 2010 reached 10% which was slightly higher than the average for the wider consumer health industry which realised 9% growth in 2010.

COMPETITIVE LANDSCAPE

  • Infinitus (China) Co Ltd ranked first in herbal/traditional products in 2010, with a market share of just over 7%. As a leading direct selling company, the company mainly focused on herbal/traditional products across its product portfolio as its core strategy, which was in line with the market trend towards herbal products in China in recent years. As a result, the company experienced rapid expansion and consolidated its company image among local consumers during the review period.

PROSPECTS

  • Healthy and sustained growth of herbal/traditional products is expected over the forecast period, with a constant value CAGR of almost 7% over 2010-2015. The preference among Chinese consumers for herbal/traditional products and the entry of a greater number of players will be the major driving forces behind long-term growth for this category.

CATEGORY DATA

  • Table 63 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 64 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 65 Herbal/Traditional Products Company Shares 2006-2010
  • Table 66 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 67 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 68 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in China - Category Analysis

HEADLINES

TRENDS

  • Medicated skin care is one of the most important categories in China’s OTC market, accounting for 21% of total OTC market size. Sales of medicated skin care in 2010 reached RMB7.3 billion, following 10% growth over 2009. The gradual deterioration of the physical environment in both urban and rural areas in China, to some extent has resulted in more people suffering from skin-related diseases in recent years, which drove sustained market growth during the review period.

SWITCHES

COMPETITIVE LANDSCAPE

  • Xian Janssen Pharmaceutical Ltd continued to be the leading company in medicated skin care in 2010, with a value share of almost 18%, more than three times the share of the second-ranked player. The company’s core brands, Daktarin, Pevisone and Triatop, all realised stable and sustained growth during the review period and maintained the company’s leading position in the market. Good brand awareness built by many years’ efforts in terms of TV advertising and an extensive distribution network established by decades’ expansion across the country are regarded as the most important factors for its success in the market.

PROSPECTS

  • Sales of medicated skin care will continue to register stable growth over the forecast period, in line with the growing population as well as improved awareness of self-medication. Sales are expected to reach RMB10.7 billion in 2015 following a CAGR of 8% in constant value terms from 2010 to 2015.

CATEGORY DATA

  • Table 69 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 70 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 71 Acne Treatments by Format: % Value Breakdown 2005-2010
  • Table 72 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 73 Medicated Skin Care Brand Shares by Value 2007-2010
  • Table 74 Acne Treatments Brand Shares by Value 2007-2010
  • Table 75 Hair Loss Treatments Brand Shares by Value 2007-2010
  • Table 76 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 77 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

NRT Smoking Cessation Aids in China - Category Analysis

HEADLINES

TRENDS

  • As the country with the largest population of smokers, China was estimated to have more than 248 million smokers in 2010 and this number is expected to increase in the following years. Due to the long history of smoking and the government’s conservative attitude towards banning smoking, demand for products that help smokers to quit was particularly weak in China compared to many Western countries. Indeed, smoking with friends or sending cigarette products as gifts are key elements of social networking in China, which, to a large extent restricts the growth of NRT smoking cessation aids in the market.

SWITCHES

COMPETITIVE LANDSCAPE

  • Limited brands were to be found in NRT smoking cessation aids, such as Nicorette gum and patches by Shanghai Johnson & Johnson. However, although the company appeared to pay considerable attention to promoting this brand, its overall performance was not as good as the company expected in 2010, due to a relatively high selling price and limited channel penetration.

PROSPECTS

  • As the tobacco industry contributes considerable tax revenue to the treasury, amounting to over RMB530 billion in 2009, the Chinese government is unlikely to take a strong anti-smoking stance over the forecast period. Hence, the smoking population of the country is expected to remain at a high level over the forecast period.

Sports Nutrition in China - Category Analysis

HEADLINES

TRENDS

  • Sports nutrition sales in China experienced healthy growth of almost 18% in current value terms in 2010, slightly higher than the 16% in 2009.

COMPETITIVE LANDSCAPE

  • Sports nutrition was once dominated by imported brands such as Prolab and Champion. However, in recent years, domestic brands have come to lead the market, and in 2010 the two well-known brands Competitor (Beijing Competitor Sports Technology Joint Stock Co Ltd) and UN (Shenzhen UN Sports Nutrition Co Ltd) claimed almost 59% of value sales.

PROSPECTS

  • The outlook for sports nutrition is very positive over the forecast period, with a constant value CAGR in excess of 10% over 2010-2015. However, given its relatively niche market base, sales are expected to reach only RMB365 million by 2015.

CATEGORY DATA

  • Table 78 Sales of Sports Nutrition: Value 2005-2010
  • Table 79 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 80 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 81 Sports Nutrition Company Shares 2006-2010
  • Table 82 Sports Nutrition Brand Shares 2007-2010
  • Table 83 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 84 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015
  • Summary 34 Sports Nutrition, Category Rankings

Vitamins and Dietary Supplements in China - Category Analysis

HEADLINES

TRENDS

  • With economic recovery and growing consumer awareness about healthcare products, accompanied by the growing ageing population and increasing number of consumers suffering health problems, the vitamins and dietary supplements market enjoyed stronger value growth in 2010, with 9% somewhat higher than the 6% in 2009. Another factor that may have contributed to this growth was the medical reform by the government, which squeezed profit margins on medicines in some retailing channels such as chemists/pharmacies, and made them more willing to sell vitamins and dietary supplements.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Amway continued to lead overall vitamins and dietary supplements sales in 2010, thanks to its sound reputation, extensive direct selling network, as well as its wide product portfolio. The company held a 16% value share in vitamins and dietary supplements in 2010, far exceeding the second largest player Infinitus with less than 4% of value sales. Amway’s Nutrilite brand ranked first in many sub-categories within vitamins and dietary supplements, including child-specific vitamins and dietary supplements, ginkgo biloba, other other herbal/traditional dietary supplements, calcium supplements, other fish oils, mineral supplements, protein powder, multivitamins and single vitamins. Take protein powder for example, Nutrilite took the lion’s share with over 89% of value sales in 2010. Despite its leading position, the company continued to work hard to diversify its product portfolio and update product formulations. Additionally, strong investments have been made in advertising and seasonal promotions. For example, to cater to Chinese gift-giving culture, the company launched a gift set during the Mid-Autumn Festival in 2010, including core products Nutrilite Protein Powder and Nutrilite Double X. All these efforts underpinned the strong position of Amway in the Chinese vitamins and dietary supplements market.

PROSPECTS

  • Vitamins and dietary supplements are expected to maintain a healthy growth trend during the forecast period, with an estimated CAGR of almost 6% in constant value terms over 2010-2015. Growing disposable incomes, improved consumer health awareness, together with worsening health problems and an ageing population, will stimulate value growth for vitamins and dietary supplements.

CATEGORY DATA

  • Table 85 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 86 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 87 Dietary Supplements by Positioning 2005-2010
  • Table 88 Vitamins and Dietary Supplements Company Shares by Value 2006-2010
  • Table 89 Vitamins and Dietary Supplements Brand Shares by Value 2007-2010
  • Table 90 Vitamins Brand Shares by Value 2007-2010
  • Table 91 Dietary Supplements Brand Shares by Value 2007-2010
  • Table 92 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 93 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015
  • Summary 35 Dietary Supplements: Brand Ranking by Positioning

Weight Management in China - Category Analysis

HEADLINES

TRENDS

  • Growth in weight management sales experienced a recovery, with 6% growth in current value terms in 2010, compared to just 1.3% growth in 2009. This was mainly driven by the double digital growth of meal replacement slimming and slimming teas. Despite of the decline of weight loss supplements and other slimming products, which fell by 7% and 8%, respectively, in 2010, the fast-growing meal replacement slimming and slimming teas sub-categories, with growth rates of 25% and 11%, respectively, drove the growth of the overall market.

COMPETITIVE LANDSCAPE

  • Thanks to its multiple distribution channels including both direct selling and store-based retailing, and sound reputation in meal replacement slimming, Herbalife retained its leading position in 2010 with a 89% value share in meal replacement slimming, which underpinned the performance of the wider weight management market.

PROSPECTS

  • The forecast period is expected to see continued growth for weight management products, with a CAGR of 4% in constant value terms over 2010-2015. By 2015, sales are expected to reach RMB7.2 billion.

CATEGORY DATA

  • Table 94 Sales of Weight Management: Value 2005-2010
  • Table 95 Sales of Weight Management: % Value Growth 2005-2010
  • Table 96 Weight Management Company Shares 2006-2010
  • Table 97 Weight Management Brand Shares 2007-2010
  • Table 98 Forecast Sales of Weight Management: Value 2010-2015
  • Table 99 Forecast Sales of Weight Management: % Value Growth 2010-2015

Wound Care in China - Category Analysis

HEADLINES

TRENDS

  • The market for wound care continued its steady performance in recent years. Thanks to consumer education campaigns from leading company, Shanghai Johnson & Johnson, in previous years, Chinese consumers have become accustomed to using sticking plasters to treat less serious injuries. After a period of sustained growth, wound care sales reached RMB552 million in 2010, following a CAGR of 6% in current value terms over 2005-2010.

COMPETITIVE LANDSCAPE

  • Yunnan Baiyao Group Co Ltd, as an industry follower, overtook Shanghai Johnson & Johnson to become the leading company in 2010, with its market share exceeding 43% in value terms. Having entered the market in 2001, Baiyao sticking plaster’s sales increased from around RMB10 million in 2001 to RMB239 million in 2010. The company used its medicated ingredients as its major selling point to compete with erstwhile leading brand, Band-Aid. Meanwhile, relatively low selling prices and an extensive distribution network guaranteed explosive growth for the brand during the review period. As a result, the brand replaced Band-Aid as the leading wound care brand in 2010.

PROSPECTS

  • The market for wound care will continue to register sustained growth over the forecast period, in line with the steady increase in the population of China. The overall market size is expected to reach RMB742 million in 2015, with a CAGR of 6% in constant value terms over 2010-2015.

CATEGORY DATA

  • Table 100 Sales of Wound Care by Category: Value 2005-2010
  • Table 101 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 102 Wound Care Company Shares by Value 2006-2010
  • Table 103 Wound Care Brand Shares by Value 2007-2010
  • Table 104 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 105 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Isoflavones
            • Lingzhi
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • E-Jiao
            • Other Other Non-Herbal Dietary Supplements
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Child-Specific Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Child-Specific Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Child-Specific Consumer Health
      • Child-Specific Analgesics
        • Child-Specific Acetaminophen
        • Child-Specific Aspirin
        • Child-Specific Combination Products - Analgesics
        • Child-Specific Diclofenac
        • Child-Specific Dipyrone
        • Child-Specific Ibuprofen
        • Child-Specific Ketoprofen
        • Child-Specific Naproxen
      • Child-Specific Cough, Cold and Allergy Remedies
        • Child-Specific Allergy Remedies
        • Child-Specific Cough/Cold Remedies
      • Child-Specific Digestive Remedies
        • Child-Specific Diarrhoeal Remedies
        • Child-Specific Indigestion and Heartburn Remedies
        • Child-Specific Laxatives
        • Child-Specific Motion Sickness Remedies
      • Child-Specific Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Child-Specific Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market Sizes
  • Company Shares
  • Brand Shares
  • Distribution
  • Analysis by Format
  • Analysis by Positioning
  • Analysis by Type
  • Herbal/Traditional vs Standard
  • Pricing

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices % growth
  • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices % growth
  • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices % growth
  • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices % growth
  • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

RELATED

Future Demographic

Country Report

Consumer Lifestyle

Country Report